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London Research Institute, Cancer Research UK, London, United KingdomABSTRACT We propose that accumulated membrane bending energy elicits a neutral sphingomyelinase (SMase) activity in
human erythrocytes. Membrane bending was achieved by osmotic or chemical processes, and SMase activity was assessed by
quantitative thin-layer chromatography, high-performance liquid chromatography, and electrospray ionization-mass spectrom-
etry. The activity induced by hypotonic stress in erythrocyte membranes had the pH dependence, ion dependence, and inhibitor
sensitivity of mammalian neutral SMases. The activity caused a decrease in SM contents, with a minimum at 6 min after onset of
the hypotonic conditions, and then the SM contents were recovered. We also elicited SMase activity by adding lysophosphati-
dylcholine externally or by generating it with phospholipase A2. The same effect was observed upon addition of chlorpromazine
or sodium deoxycholate at concentrations below the critical micellar concentration, and even under hypertonic conditions. A
unifying factor of the various agents that elicit this SMase activity is the accumulated membrane bending energy. Both hypo-
and hypertonic conditions impose an increased curvature, whereas the addition of surfactants or phospholipase A2 activation
increases the outer monolayer area, thus leading to an increased bending energy. The fact that this latent SMase activity is
tightly coupled to the membrane bending properties suggests that it may be related to the general phenomenon of stress-
induced ceramide synthesis and apoptosis.INTRODUCTIONMembrane curvature is generated as a result of a complex
interplay among membrane proteins, lipids, and physical
forces that are applied to the membrane surface (1). Helfrich
(2) introduced the concept of spontaneous curvature Js as a
physical factor characterizing the tendency of a flat
membrane to bend. To change membrane curvature, forces
have to be applied to the membrane and energy has to be
invested. Membrane resistance to deviations of curvature
from Js is determined by the bending rigidity k. The latter
is determined mainly by the bilayer composition at a given
temperature. According to the Helfrich bending model,
the bending stress, or bending moment t, depends on the
rigidity and the difference between the imposed and the
spontaneous curvature:
t ¼ kðJ  JsÞ: (1)
As described in Eq. 1, in terms of the Helfrich bending
model (2), the bending stress is related to the difference
between the actual and the spontaneous curvature (J  Js).
The accumulated bending energy per unit area (fB) required
to deform a monolayer from its spontaneous curvature Js to
a mean curvature J is given bySubmitted September 15, 2011, and accepted for publication March 12,
2012.
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kðJ  JsÞ2: (2)For years, sphingolipids have been considered as mere
structural lipids in cells; however, over the past decade
their role in cell signaling has been highlighted. A particu-
larly well studied sphingolipid is ceramide, which acts
as an important second messenger in cell death processes
(3). It has also been described as having a putative role as
an inducer of cell proliferation (4). Ceramide may be
synthesized via two different pathways: de novo synthesis
or sphingomyelin (SM) hydrolysis. The first one occurs
in the endoplasmic reticulum (5) via condensation of
L-serine with palmitoyl-CoA to form 3-ketosphinganine.
The second pathway appears to occur mainly in the plasma
membrane, as a result of sphingomyelinase (SMase) activa-
tion by an appropriate effector of the sphingolipid signaling
pathway (6).
Lang et al. (7), investigating the processes that occur
during erythrocyte death, described an increase in ceramide
content after a 15-h incubation of human red blood cells
(RBCs) in a hypertonic medium. Other authors (8,9) had
reported some years previously that incubation of chicken
erythrocytes in a hypotonic medium resulted in the hydro-
lysis of SM. Because of the newly acknowledged impor-
tance of ceramide signaling in RBCs as well as in other
cells, it was important to explore and define any latent
SMase activity in human erythrocytes. This work dealsdoi: 10.1016/j.bpj.2012.03.020
2078 Lo´pez et al.with the characterization of a SMase activity in human
RBCs that is elicited upon an increase in the membrane
bending energy. We monitored the bending-energy-
dependent decrease in SM content by using three different
techniques, namely, thin-layer chromatography (TLC),
reverse-phase high-performance liquid chromatography
(RP-HPLC), and electrospray ionization mass spectrometry
(ESI-MS). Up to seven different groups of SMases have
been described (10). Some of those that are present in
mammals are active at neutral pH only in the presence of
magnesium ions. One type of neutral SMase, nSMase-2
(11), has been localized in the plasma membrane, is magne-
sium-dependent, and is inhibited by nSMase inhibitors such
as GW4869. The activity described in this work may belong
to this group of neutral SMases.MATERIALS AND METHODS
Materials
Silica G-60 plates and solvents for chromatographic assays were obtained
from Merck (Darmstadt, Germany). N-2-hydroxyethylpiperazine-N0-2-
ethanesulfonic acid (HEPES) was purchased from Apollo Scientific Ltd.
(Cheshire, UK). Trypsin, a-chymotrypsin, chlorpromazine (CPZ), phospho-
lipaseA2 (PLA2) fromhog pancreas,GW4869, and detergentswere obtained
from Sigma Aldrich (St. Louis, MO). Spiroepoxide was purchased from
Alexis (San Diego, CA). N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
s-indacene-3-dodecanoyl)sphingosylphosphocholine (BODIPY-C12-SM)
and 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosyl-
phosphocholine (NBD-C6-SM) were obtained from Molecular Probes
(Eugene, OR). 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)
sphingosine (NBD-C6-ceramide) was synthesized according to Bedia et al.
(12). Mass spectrometry standards 1,2-dilauroyl-sn-glycero-3-phosphocho-
line (DLPC), 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE),
1,2-dilauroyl-sn-glycero-3-[phospho-L-serine] (DLPS), 1,2-dilauroyl-sn-
glycero-3-phosphate (DLPA), and 1,2-dilauroyl-sn-glycero-3-[phospho-
rac-(1-glycerol)] (DLPG) were purchased from Avanti Polar Lipids
(Alabaster, AL), and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylinositol
(DPPI) was obtained from Echelon (Salt Lake City, UT).Blood sample preparation
Blood was withdrawn from healthy donors and washed three times in buffer
A (isotonic) containing 32 mM HEPES, 125 mM NaCl, 1 mM MgSO4,
1 mM CaCl2, 5 mM KCl, 5 mM glucose, pH 7.2, 300 mOsm. RBCs
were prepared by a centrifugation method consisting of a single centrifuga-
tion step at 300  g to eliminate platelets and interface whitish layer,
followed by several washes with the assay buffer. Occasionally, ultrapure
RBC preparations were obtained via Beutler et al.’s (13) method. The latter
method is said to eliminate 99% leukocytes and 90% platelets. It is based on
a filtration step through a mixture of microcrystalline cellulose and a-cellu-
lose (1:1 by weight) followed by several washes by centrifugation with the
assay buffer. Erythrocytes (5% hematocrit) are incubated at 37C in
different media. Under isotonic conditions, erythrocytes are incubated in
buffer A. For hypotonic conditions, cells are diluted in buffer B (hypotonic)
containing 32 mM HEPES, 1 mM MgSO4, 1 mM CaCl2, 5 mM glucose,
pH 7.2, ~30 mOsm. For hypertonic conditions, the osmolarity of buffer A
is increased up to ~900 mOsm by addition of sucrose (buffer C) and acidic
conditions are achieved with buffer D containing 32 mM sodium acetate,
1 mM MgSO4, 1 mM CaCl2, 5 mM glucose, pH 5.0, ~30 mOsm. In
some cases, 0.1 mM ZnCl2 is added to buffer D.Biophysical Journal 102(9) 2077–2085TLC
After cell incubation, lipid extraction is accomplished using a modification
of a method described elsewhere (9). Briefly, to improve the chromato-
graphic resolution of SM and prevent it from overlapping with plasmalogen
and other glycerophospholipids, a 600 ml cell suspension is incubated with
100 mM HCl at 37C for 30 min. Afterward, alkaline hydrolysis is per-
formed with KOH added to reach a concentration of 250 mM, followed
by incubation at 70C for 90 min. Then 3 ml chloroform/methanol
(2:1, v/v) are added to the hydrolyzed cell suspension, followed by vigorous
vortexing. Samples are centrifuged at 1500  g for 15 min, and the lower
lipid-containing chloroform phase is mixed with 4 ml water/methanol
(3:2, v/v) and centrifuged under the same conditions. The lower organic
phase is evaporated under nitrogen flow and the lipid film is resuspended
in 80 ml chloroform. Lipid extractions are applied to silica G60
plates and developed in chloroform/methanol/water/toluene/diethylether
(60:35:8:2:1, v/v). Lipids are stained with 10% sulfuric acid (v/v) followed
by heating at 110C for 15 min. Lipid quantitation is accomplished by
densitometry in a GS-800 densitometer with the Quantity One software
from Bio-Rad Laboratories (Hercules, CA).RP-HPLC
RP-HPLC measurements are performed with a Waters 2690 Alliance
System and Waters 2475 fluorescence detector (Milford, MA), using
a C18 reversed-phase column (Kromasil 100 C18 15  0.4 cm, 0.5 mm;
Teknokroma, Barcelona, Spain) eluted with mixtures of water and acetoni-
trile containing 0.1% trifluoroacetic acid, at 1 ml/min. Empower Software
from Waters Corp. (Milford, MA) is employed for data acquisition and
processing.
Erythrocytes (5% hematocrit dilution) are incubated with 2 mMNBD-C6-
ceramide, NBD-C6-SM, or 2 mM BODIPY-C12- SM with gentle rolling for
30 min at 4C. The cells are then washed twice in buffer A, followed by
incubation in an osmotic-shock buffer at 37C. The reaction is terminated
in ice; cells are frozen in liquid nitrogen, lyophilized, and kept at 20C.
At the time of analysis, 0.2 ml of water are added to the samples. The
samples are sonicated for 30 s, vigorously mixed with 0.8 ml methanol,
and centrifuged at 10,000  g for 3 min, and the supernatant is placed in
HPLC vials. Fluorescent NBD-C6-ceramide and its metabolites (lex ¼
465 nm, lem ¼ 530 nm) are eluted isocratically with a mobile-phase
mixture of 20% water and 80% acetonitrile, whereas a linear gradient of
mobile phase is used to separate BODIPY-C12- SM and its metabolites
(lex ¼ 505 nm, lem ¼ 530 nm). The elution starts from 90% acetonitrile
and 10% water, and continues up to 99% acetonitrile and 1% water in
5 min. These conditions are maintained for a further 10 min. Equilibration
to the starting elution conditions lasts 5 min.SM quantitation by ESI-MS coupled to HPLC
All glassware is silanated. An internal standard solution is prepared con-
taining DLPC, DLPA, DLPS, DLPG, DLPE, and DPPI at 100 mg/ml in
chloroform/methanol/water (5:5:1, v/v). Freeze-dried biological samples
are resuspended in 200 ml of distilled water and extracted according to
a modified Folch procedure (14). Then 200 ml of sample and 2 mg of internal
standard are added to 4 ml of ice-cold acidified chloroform/methanol
(2.5:1; v/v) in a glass vial. The mixture is probe-sonicated for 10 s and
left at room temperature for 1 h. Samples are filtered through a 0.22 mm
Durapore membrane, supplemented with 0.2 volumes 200 mM K4EDTA,
and centrifuged at 800  g for 15 min at 4C. The organic lower phase
is dried at 37C under nitrogen and resuspended in 100 ml of chloroform/
methanol/water (90:9.5:0.5, v/v). Mass spectrometry lipid analysis is
carried out on an Applied Biosystems API 3000 instrument (Foster City,
CA) equipped with an electrospray ionization source. Lipids are separated
using a normal phase Luna silica (2) 3 mm column from Phenomenex
Sphingomyelinase Activity and Membrane Bending 2079(Torrance, CA). A gradient elution protocol (15) from 100% phase A
containing chloroform/methanol/water/ethylamine (90:9.5:0.5:7; v/v) to
70% phase B chloroform/acetonitrile/methanol/water/ethylamine (30:30:
35:5:10, v/v) over 20 min is used to separate SM from phosphatidylcholine
(PC). PC lipids elute between 10 and 12 min, and SM lipids elute between
15 and 19 min. Phospholipids are ionized at þ4kV, 300C. SM species are
determined using multiple reaction monitoring scans in which the choline
group (þ184 m/z) is the specific fragment for SM and PC lipids. The colli-
sion energy is þ 37V for SM lipids and þ 52V for PC lipids. Moles of SM
and PC lipids are back-calculated from the internal standard and lipid peak
areas by means of an in-house macro written in Excel.FIGURE 1 SMase activity depending on the osmotic shock. SM from
human erythrocytes was quantified after incubation in different conditions:
control (isotonic, buffer A,:) and hypotonic (buffer B,C,). RBCs were
prepared according to the regular centrifugation method (C) or Beutler
et al.’s (13) method for preparing ultrapure erythrocytes (; see Materials
and Methods). Mean5 SE (n ¼ 9–12). **Significant differences between
control and hypotonic conditions (p < 0.01).Flickering spectroscopy
The bending modulus of erythrocytes was measured both under isotonic
conditions and in the presence of the curvature-promoting drugs CPZ and
sodium deoxycholate (Na DOC) at subsolubilizing concentrations. For
this purpose, 50 ml of 0.1% hematocrit diluted in isotonic buffer were
loaded on a coverslip. To avoid the glass effect (16), the coverslips were
previously incubated with 50 ml 0.5% casein aqueous solution for 15 min
and washed abundantly with isotonic buffer. A few minutes were necessary
to allow the erythrocytes to sediment. In the case of stress conditions, once
an erythrocyte group was targeted, 10 ml of CPZ or Na DOC (0.8 mM final
concentration) were added and gently stirred. Just after drug addition, 30-s
videos were taken every minute and the thermal fluctuations of single eryth-
rocytes were tracked by fast CCD microscopy in the phase contrast mode
(Nikon TE2000-U inverted microscope with an immersion oil objective,
100). Flickering spectroscopy, which is extensively described elsewhere
(17), is well suited to measure bending properties. Briefly, the curvature
fluctuations are described in Fourier series at the equatorial plane and the
average amplitudes of the Fourier modes are compared with the classical
Helfrich spectrum for thermal bending modes,
PðqÞ ¼ kBTðsq2 þ kq4Þ; (3)
obtained as a time average of the quadratic fluctuations (the time average
was calculated over 500 consecutive images taken at 14 fps; s is themembrane tension, k is the bending stiffness, and q is the wave vector).
At sufficiently large q, qz 2/R (> s/k), bending modes largely dominate,
so when integrated over the equatorial plane, the spectrum may simply vary
as Px(qx)z kBT/kqx
3.Statistics
Unless otherwise indicated, the data are the average values of three inde-
pendent measurements 5 1 SD. Student’s t-test was used to assess the
significance of the observed differences.RESULTS
SMase activity assays
TLC
SMase activity was detected in human erythrocytes after a
hypotonic osmotic shock, as a decrease in SM in the first
3–6 min after the shock (Fig. 1). SM analysis by TLC and
densitometry showed no variations in the SM content under
isotonic conditions, whereas it decreased notably after incu-
bation in a hypotonic medium with a specific activity of
31.8 nmoles/min  mg ghost protein. After a 6-min incuba-
tion, the SM content decreased by 17.5% under hypotonic(hemolytic) conditions. After that time, SM levels started to
increase again, suggesting the existence ofmechanisms to re-
generate the sphingolipid. Under isotonic conditions, the SM
levels remained constant throughout the 20-min incubation.
The described neutral SMase activity could be driven by
a small amount of contamination by lymphocytes. To test
this possibility, we obtained a highly purified erythrocyte
preparation according to Beutler et al.’s (13) method. This
protocol is based on a filtration step through a mixture of
microcrystalline cellulose: a-cellulose (1:1) followed by
several washes with the assay buffer. According to the
above-mentioned protocol, 99% leukocytes and 90% plate-
lets are eliminated from the RBC fraction. The regular
centrifugation method described here is based on a centrifu-
gation step at 300 g to eliminate platelets and white blood
cells (the interface whitish layer) and several washes with
the assay buffer. Both methods yield a very similar SMase
activity under hypotonic conditions (Fig. 1), confirming
that the activity is indeed located in RBCs.
The initial rates measured in our system are comparable
to those found in chicken RBC plasma membranes (9).
However, an important difference is that in human erythro-
cytes, SM depletion is corrected, perhaps by de novo resyn-
thesis, after a few minutes, whereas in chicken cells SM
degradation proceeds for >1 h, until most of the SM in
the cell has been degraded. Thus a mechanism appears to
exist in humans, but not in chickens, that helps maintain
a constant SM concentration in erythrocytes.
HPLC
To assess both the variation in SM content and changes
in ceramide levels, we labeled the erythrocytes withBiophysical Journal 102(9) 2077–2085
2080 Lo´pez et al.NBD-C6-SM and subjected them to hypotonic shock in
buffer B. HPLC analysis of samples showed a continuous
increase in NBD-C6-Cer (Fig. 2 A), which correlates with
the disappearance of NBD-C6-SM (Fig. 2 B). Isotonic
conditions, in which both NBD-labeled sphingolipids re-
mained constant, were used as a negative control.
Approximately 1% of added NBD-C6-SM is degraded in
the first 6 min (i.e., one order of magnitude less than the
native lipid). This can be explained by a decreased affinity
of the enzyme for the labeled substrate. In fact, hydrolysis
was not observed for another fluorescently labeled SM
(BODIPY-C12-SM; data not shown). Nevertheless, HPLC
data showing the symmetric disappearance of NBD-C6-
SM and appearance of NBD-C6-Cer (Fig. 2) qualitatively
confirm the presence of a SMase activity that is detected
under osmotic stress conditions but not under more-physio-
logical (isotonic) conditions.
The data in Fig. 2 also report on a continued SMase
activity that remains unquenched after 20 min. This supports
the idea that the SMase activity elicited by hemolysis in
human RBCs is similar to that found in chicken RBCsFIGURE 2 SMase activity in human RBCs labeled with NBD-C6-SM.
Cells were labeled with NBD-C6-SM, incubated in hypotonic (C) or
isotonic (:) buffer, and analyzed after elution in an HPLC column. (A)
Variations of NBD-C6-ceramide. (B) Variations of NBD-C6-SM. Mean 5
SD (n ¼ 3).
Biophysical Journal 102(9) 2077–2085(8,9), although in humans a compensating biosynthetic
activity occurs.
SM biosynthesis from ceramide was monitored by HPLC
on human cells to which NBD-C6-Cer had been added. As
shown in Fig. S1 of the Supporting Material, irrespective of
isotonic and hypotonic conditions, a biosynthetic pathway
exists that converts ceramide into SM. This can explain
the absence of a continuing degradation and the minima in
SM contents observed after 6 min (Fig. 1).
HPLC-ESI-MS/MS
Tandem HPLC-ESI-MS/MS experiments were performed to
confirm the data observed by TLC and HPLC assays. In this
case, we analyzed three of the most abundant phospholipids
in the human erythrocyte plasma membrane (18), namely,
SM, PC, and phosphatidylinositol (PI; Fig. 3). After a 6-
min incubation under hypotonic conditions, 14% of the
initial SM was hydrolyzed, a reduction similar to the one
observed by the TLC method (17.5%). No significant differ-
ences in the PC or PI content were detected.
HPLC-ESI-MS/MS demonstrates the disappearance of
individual SM species in the erythrocyte membrane after
osmotic shock. The results are summarized in Table S2.
Eighty percent of the sphingolipid is found in five of
the 16 species detected (16:0, 18:0, 22:0, 24:0, and 24:1).
Of interest, not every species is hydrolyzed at the same
rate, varying from 3% hydrolyzed in 6 min (20:1) to
19.3% cleaved in the same period of time (d16:0). However,
the data do not indicate a clear pattern relating lipid
structure to hydrolysis rate. Although the most abundant
species (16:0) is extensively cleaved, one of the less
abundant (d24:0) is also highly degraded, and others (e.g.,
18:1) are present in low proportions and are scarcely
hydrolyzed.FIGURE 3 Mass spectrometry analysis of different lipids in RBCs.
Erythrocytes were incubated in hypotonic buffer at 37C for 0 min (dark
bars) and 6 min (gray bars). After lipid extraction, amounts of SM, PC,
and PI were analyzed by mass spectrometry as described in Materials
and Methods. *Significant difference from time 0 min (p < 0.05).
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We performed a number of experiments to understand why
the hypotonic conditions elicited a SMase activity. An
important clue arose from studies using detergents. Deter-
gents (or surfactants) are known to modify the activity of
membrane enzymes in various ways (19,20). As shown in
Table 1, surfactants of widely different chemical structures,
such as CPZ, Na DOC, and lysoPC (all at concentrations
well below their critical micellar concentrations to ensure
that they would interact with the membrane in the form of
monomers (21)) induced SMase activity in RBCs under
isotonic conditions to a similar extent as did hypotonic
shock (Table 1). PLA2, which cleaves PC (among other
phospholipids) to lysoPC and free fatty acids, also induced
SMase activity (Table 1). One factor that is common to
hypotonic shock, addition of surfactants, and enzymatic
cleavage of phospholipids is the increase in membrane
bending energy. In the case of hypotonic shock, bending
energy is developed through an increased bilayer curvature
(J  Js > 0), because RBCs become spherical and break
down to smaller (z2 mm) spherical vesicles, under these
conditions (22). The addition of surfactants causes the inser-
tion of a large fraction of them predominantly into the outer
lipid monolayer (23). In addition, PLA2 phospholipid
cleavage has the effect of increasing the bending energy
because the area occupied by the free fatty acid and lyso-
phospholipid is higher than that occupied by the original
phospholipid (24,25).
We performed a further experiment to test the bending
energy hypothesis by assaying SMase activity under hyper-
tonic conditions. In principle, RBCs should shrink under
these conditions, and membrane curvature should increase
as a result of decreasing cell radius. In fact, these conditions
also elicit a SMase activity, as shown in Table 1. Note that
under all conditions listed in Table 1, the SM levels recov-
ered after a few minutes (data not shown), suggesting that
in all cases the same phenomenon was being detected.
Thus, a number of very different, even opposing causes
(hypotonic and hypertonic shocks, surfactant addition, and
lipid degradation) are having a common effect, i.e., SMaseTABLE 1 SMase activity elicited in human RBCs after various
treatments causing increased accumulated membrane
bending energy
RBC treatment SMase activity (nmol SM/min  mg protein)
None 2.35 4.3
Hypotonic shock 31.85 3.5
0.8 mM CPZ* 16.85 6.2
0.8 mM Na DOC* 26.05 4.1
13.2 mM lysoPC* 22.55 11.2
4 U/ml PLA2 6.25 0.3
8 U/ml PLA2 18.65 5.7
Hypertonic shock 16.851.3
*Detergents used well below their critical micellar concentrations.activation. The only common factor we detect in this multi-
plicity of causes is that they all contribute to develop an
accumulated membrane bending energy. Conversely, the
molecular area of ceramides is smaller than that of SM
(26), so that SMase has the effect of decreasing the outer
monolayer area and thus the bilayer curvature and the
bending energy. Consequently, SMase activity counteracts
the increased bending energy, and this may explain the
arrest of the enzyme activity after a few minutes. At this
timescale, flip-flop motions may occur that further decrease
the difference between the outer and inner monolayer areas
(see Discussion).
Bending modulus measurements
The bending modulus of erythrocytes, both in the native
state and in the presence of drugs, was measured by flick-
ering spectroscopy. RBCs under isotonic conditions had
a bending modulus k z 1.5  1020J (Fig. 4 A) similar to
previously published values (see Evans et al. (27) and refer-
ences therein). k is a material parameter that depends on the
lipid composition. The SM-to-ceramide conversion pro-
moted by SMase increases the proportion of ceramides in
the plasma membrane, which should become more rigid
due to the presence of the newly synthesized ceramides
(28,29). In fact, when 0.8 mM CPZ, a reagent that elicited
SMase activity (Table 1), was added to erythrocytes, clear
changes in cell morphology were observed (Fig. 4 B).
More to the point, CPZ gave rise to a 3.5-fold increase in
k, with a maximum 5 min after drug addition (Fig. 4 B).
This corresponds to the maximum of SMase activity after
CPZ addition (data not shown). The resynthesis of SM
from ceramides (see Figs. 2 and 3) then decreased the value
of k once the maximum of SM conversion was reached. A
similar increase in k was observed as a consequence of
SMase activity promoted by DOC (Fig. 4 C). In the same
figure, data taken from Evans et al. (27) are included that
correspond to hypo- and hypertonic erythrocyte membranes
in which, according to our observations, SMase activity and
ceramide formation might have taken place. Therefore, vari-
ations in k due to the presence of newly formed ceramides in
the plasma membrane constitute by themselves a different
mechanism by which the bending energy can be modified.SMase activity characterization
We further characterized the bending energy-induced
SMase activity in human erythrocytes under hypo- and
hypertonic conditions to study the influence of different
conditions and reagents. As shown in Table S1, pH 5.0
totally abolishes SMase activity. In an important group of
SMases, known as acidic SMases (10), the optimum pH is
close to 5.0. Moreover, the secretory SMases (30), which
are known to proceed from the same gene as acidic SMases,
require Zn2þ for their function. However, the data in
Table S1 show that Zn2þ failed to elicit any SMase activityBiophysical Journal 102(9) 2077–2085
FIGURE 4 (A) Typical fluctuation spectra for different erythrocytes in
the native state. The amplitudes follow a qx
3 decay (straight line), which
is characteristic of a pure bending motion. These fluctuations are well
described by the Helfrich spectrum with a bending modulus of 1.5 
1020J. (B) Changes in the erythrocyte bending modulus in the presence
of 0.8 mM CPZ. Mean5 SD (n ¼ 10). Representative cell morphologies
are shown at various times after drug addition. (C) Erythrocyte membrane
bending moduli in control cells and after various treatments that elicit
SMase activity: 0.8 mM CPZ, 5 min after drug addition; 0.8 mM Na
DOC, 5 min after drug addition; and hyper and hypo RBCs under hyper-
and hypotonic conditions, respectively (data taken from Fig. 8 b of Evans
et al. (27)).
2082 Lo´pez et al.at pH 5.0. Thus, these data suggest that the activity found in
human RBCs may belong to the group of neutral SMases
(10). In agreement with most other neutral SMases (31),
SMase activity from human RBCs is activated by Mg2þ
and Ca2þ (Table S1). This is at variance with the observa-
tions in chicken erythrocytes (8), where a (slight) activation
by Mg2þ and an actual inhibition by Ca2þ were found.
Further proof that the SMase described above is related
to the neutral SMases comes from the fact that in the pres-Biophysical Journal 102(9) 2077–2085ence of nSMase inhibitors such as GW4869 (32) or spiroep-
oxide (33), SM hydrolysis is largely or fully inhibited
(Table S1). Trypsin and a-chymotrypsin proteases were
used under conditions in which proteins on the surface of
the RBCs were hydrolyzed (34), and SMase activity was
partially inhibited by trypsin and completely abolished by
a-chymotrypsin (Table S1). These data could suggest an
association of SMase activity with a membrane protein
that is accessible from the cell surface. Note that all the
various agents and conditions tested had qualitatively iden-
tical effects on SMase activities elicited by hypo- and hyper-
tonic buffers. This observation strongly reinforces the idea
that both opposite factors are eliciting a single enzyme
activity.DISCUSSION
Our main observation in this study is that SMase activity
may be elicited in human RBCs by a number of factors,
which have in common the ability to increase the membrane
bending energy.Building up the bending energy
The spontaneous curvature model in Eqs. 1 and 2 recognizes
that the inner and outer leaflets of a bilayer can be compo-
sitionally asymmetric. In this case, the spontaneous curva-
ture reads:
JBs ¼

Jouts  Jins

2
; (4)
which is zero for a symmetric bilayer (Jouts ¼ Jins ) but finite
depending on the difference between the topological curva-
tures of the lipids in each monolayer.
Lipid asymmetry may also produce a difference between
the molecular areas of the outer and inner monolayers
(Aout – Ain s 0). Consequently, if the two leaflets are
mechanically coupled, the bilayer takes a spontaneous
curvature proportional to the net area difference (35):
JAs ¼
1
d
$
Aout  Ain
Aout þ Ain; (5)
where d is the monolayer thickness.
In the uncoupled case, every monolayer is free to slide
past the other, thus relieving longitudinal stress upon differ-
ence area. Spontaneous curvature is not expected in this
sliding case, which is characteristic of single lipid bilayers
with no leaflet interdigitation. In biological membranes,
due to intermonolayer lipid tail mismatch or transmembrane
proteins, a certain degree of coupling is present. Therefore,
if both effects are taken into account, a measurable change
of the spontaneous curvature and hence of the bending
energy is expected in RBCs when lipid asymmetry is
induced in one of the monolayers.
Sphingomyelinase Activity and Membrane Bending 2083Under the conditions of our experiments, RBC membrane
bending is achieved through two different mechanisms: 1),
changes in osmotic pressure that impose an increased curva-
ture; or 2), increases in the outer monolayer area through
insertion of surfactant molecules or cleaving of phospho-
lipids. Note that both hypotonic shock and hypertonic shock
lead ultimately to the same effect of increasing the bilayer
curvature (hypotonic shock by generating smaller, spherical
vesicles, and hypertonic shock by shrinking RBCs; Fig. 5).
Additionally, the accumulated energy may be also
increased through increments in the bending modulus k by
the newly synthesized ceramide in the plasma membrane.
The solid character of ceramides must increase the
membrane rigidity (28,29). This is evident in Fig. 4, where
the bending modulus was increased when the SMase
activity was triggered by CPZ or DOC. In this context,
Evans et al. (27) measured changes in k induced by hyper-
tonic and hypotonic conditions and found that in both cases
the bending modulus increased by two- to threefold in
the absence of externally added drugs, probably due to the
presence of the newly formed ceramide in the plasma
membrane.Bending stress relaxation
Although the change in RBC morphology was irreversible
under membrane stress, the same principles may explain
why SMase activity is markedly decreased after a few
minutes under our conditions. First, the enzyme action itself
gives rise to ceramide, whose mean molecular area is
smaller than that of SM (26,36), so that Aout and conse-
quently Js
B decrease, tending to recover the equilibriumFIGURE 5 Model showing the mechanisms by which the accumulated
bending energy of the membrane is increased in human RBCs. (a) Osmotic
shock (hypo- or hypertonic) leads to a reduction of the cell radius, thereby
increasing the spontaneous curvature of the bilayer (JS
B). (b) Insertion of
molecules into the outer monolayer increases the area of the membrane
outer leaflet and a subsequent increase in the spontaneous curvature (JS
out).values. Second, although surfactants and PLA2 are added
from the outside of the cell, thus increasing Aout, there
will be a tendency for the lipids to flip into the internal
monolayer, thus decreasing the area difference (37). In addi-
tion, SM-to-ceramide conversion is known to increase the
phospholipid flip-flop rate in membranes (38,39), in
conjunction with the rapid translocation of ceramides (40),
thus effectively contributing to the relaxation of bending
stress due to differences in monolayer areas. Concerning
the bending modulus, the observed resynthesis of SM
from ceramide in the late minutes after cell stress could
be the source of the bending modulus decrease observed
by flickering measurements (Fig. 4 B).
DLPC is one of the amphipathic molecules that induce
echinocytosis when incorporated into human RBC
membranes at a final concentration of 0.2 mM (5% of the
total cell phospholipid) (41), and echinocytes produced by
DLPC are stable for hours. One could suppose that they
should rapidly reverse to the normal form due to the bending
induced by conversion of SM to ceramide in the outer
monolayer. However, SM contents in human RBC accounts
for ~20% of total phospholipid in the membrane (42), and
our results indicate a maximum decrease of SM levels of
~15%. This means that after a 6-min induction of SMase
activity, ~3% of phospholipid contents have been converted
to ceramide. The higher amount of inserted amphipathic
molecules as compared with the amount of produced ceram-
ide, and the ensuing reconversion of ceramide into SM may
explain why the conversion of SM into Cer cannot reverse
the DLPC-induced echinocytosis effect.Proteins can sense membrane curvature
Examples of the activation of intracellular signaling cascades
in response to physical changes in the environment have
been reported (43); however, the idea thatmembrane proteins
can sense curvature is a novel one (1). It has emerged with
the identification of proteins that have membrane-binding
affinities that depend on the radius of membrane curvature.
ArfGAP1, a protein involved in coated-vesicle formation
(44), displays a GTPase-activating activity that increases
with membrane curvature. Ahyayauch et al. (45) described
the increased activity of a bacterial PI-dependent phos-
pholipase C with vesicle curvature. More recently, Urbina
et al. (46) found that the SMase activity of Clostridium
perfringens a-toxin increases with curvature, whereas the
phospholipase C activity of the same toxin decreases with
decreasing vesicle radius. According to another report (47),
the membrane lytic activity of the bacterial toxin d-lysin
is influenced by the bending modulus. The fact that the
SMase in our study could catalyze the onset of a signaling
(apoptotic) cascade lends additional interest to our observa-
tion. The activationmechanism in our experiments is unclear.
Assuming that the neutral SMase is localized to the inner
leaflet of the membrane, membrane bending would lead toBiophysical Journal 102(9) 2077–2085
2084 Lo´pez et al.a tighter packing of this leaflet, and thus the mechanism
would not simply consist of a facilitated access of the ester
bonds to the active site, as one could argue if the hydrolysis
took place in the outer leaflet. Reconstitution experiments
with liposomes might prove useful to clarify the mechanism.Physiological implications
The observation of a latent nSMase activity could have
physiological implications. In a series of studies, Lang
et al. (48,49) related hyperosmotic shock to SMase activa-
tion, ceramide production, and apoptosis (eryptosis). How-
ever, these authors detected a maximum of ceramide
production many hours after the osmotic shock, and found
that SMase activation is secondary to PLA2 activation and
release of platelet activating factor (49). In addition, the
SMase activity found by Lang et al. (48) appears to be
a fumonisin-sensitive, acidic SMase, which would be very
different from the one described above. In addition, it is
known that nSMases are activated in the first minutes after
stimulation by an extracellular signal such as TNF (50).
This correlates with the activation times observed here.
Also, Lacour et al. (51) described the hydrolysis of SM in
HT29 human cancer cells with a maximum ceramide
production after 5-min incubation with the antitumoral
drug Cisplatin. Maestre et al. (52) showed the activation
of nSMase activity in U937 leukemia cells after treatment
with the anthracyclines doxorubicin and daunorubicin. Of
interest, the SM level was decreased by ~20–22% in the first
6 min, after which the SM levels increased back to initial
levels, as found in our experiments.
The mechanical stress induced in the membranes by
osmotic changes is similar in nature to that caused by blood
flow in the capillary system. One could expect that in both
cases SM hydrolysis, an ancient stress signal (53), is trig-
gered. It has also been suggested that ceramide might induce
flip-flop lipid movements when enzymatically produced
from SM by SMase (38,39), thus bringing phosphatidylser-
ine to the RBC outer surface and stimulating phagocytic
removal of the stress-impaired cells. Moreover, membrane
pores were formed in erythrocytes by hypotonic hemolysis,
which gave rise to a transmembrane redistribution of phos-
pholipids of the cell membrane (54). This scramblase
activity was previously hypothesized to be a consequence
of lateral mechanical stress (29,55). In model lipid systems,
the enzymatic activity of SMase in SM-containing vesicles
(5% mol of total lipids) was observed to trigger drastic
bilayer perturbations that provoked the formation of
membrane defects, as revealed by optical microscopy and
atomic force microscopy (55). It should be noted in this
respect that there is no de novo ceramide synthesis in
RBCs (56); thus, SM and other complex sphingolipids are
the only sources of ceramide in these cells. In RBCs, the
main pool of SM that is accessible to SMase is at the outer
monolayer, and thus the induced mechanical stresses couldBiophysical Journal 102(9) 2077–2085be enhanced by the enzymatic SM-to-ceramide conversion.
The evidence of a mechanical connection between SMase
and scrambling activity suggests a strong congruence
between both enzymatic systems.SUPPORTING MATERIAL
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